AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Omacron Vaccine
E arby vac, from the data we've seen on the variance, is holding up pretty well. I mean, this is not going to be a big question of moving forward,. It looks like omacron could potentially be in the rear of mirror in the next few weeks. Even though maderna and fis are looking at producing omacron variance, i'm not certain they're ever going to be used. And so on that basis, it might be that just sticking op the original lineage might be the best way to go.